SEI US Large Company Equity Class FRegister to Unlock Ratings |
Performance History | 31-03-2024 |
Growth of 1,000 (CAD) | Advanced Graph |
Fund | 8.5 | 23.7 | -8.6 | 15.1 | 13.1 | |
+/-Cat | -4.3 | 0.3 | 4.3 | -3.6 | 1.1 | |
+/-Idx | -10.3 | -1.0 | 5.0 | -8.0 | -0.1 | |
Category: US Equity | ||||||
Benchmarks: Morningstar US Market TR CAD |
Key Stats | ||
NAV 17-04-2024 | CAD 14.38 | |
Day Change | -0.62% | |
Morningstar Category™ | US Equity | |
ISIN | - | |
Fund Size (Mil) 17-04-2024 | CAD 1044.65 | |
Share Class Size (Mil) 17-04-2024 | CAD 83.03 | |
Max Initial Charge | - | |
Ongoing Charge - | -% |
Investment Objective: SEI US Large Company Equity Class F |
The investment seeks to provide long-term growth of capital and income, primarily through investment in a diversified portfolio of equity securities of large U.S. companies listed on recognized stock exchanges. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Hintz 29-06-2021 | ||
Stephen Dolce 01-07-2005 | ||
Inception Date 17-04-2006 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 TR CAD | Morningstar US Market TR CAD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SEI US Large Company Equity Class F | 31-03-2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 3.93 |
Amazon.com Inc | Consumer Cyclical | 2.32 |
Johnson & Johnson | Healthcare | 1.90 |
Exxon Mobil Corp | Energy | 1.61 |
Merck & Co Inc | Healthcare | 1.59 |
Increase Decrease New since last portfolio | ||
SEI US Large Company Equity Class F |